Aspira Pathlab & Diagnostics Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

10.29

10.29

10.29

9.29

8.19

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

-2.47

-2.43

-6.91

-5.49

-3.00

Loan funds

Secured loans

5.89

5.79

6.18

6.87

6.75

Unsecured loans

-

-

-

-

-

Total

13.71

13.65

9.57

10.67

11.94

Uses of funds

Fixed assets

Gross block

14.32

16.61

12.32

12.33

11.33

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

6.31

7.03

4.57

3.64

2.43

Net block

8.01

9.57

7.75

8.70

8.90

Capital work-in-progress

-

-

-

-

-

Investments

-

-

-

-

-

Net current assets

Current assets, loans & advances

9.33

8.56

4.02

5.64

5.90

Less : current liabilities & provisions

3.63

4.49

2.21

3.66

2.86

Total net current assets

5.70

4.07

1.81

1.98

3.04

Miscellaneous expenses not written

-

-

-

-

-

Total

13.71

13.65

9.57

10.67

11.94

Notes:

Book value of unquoted investments

-

-

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

102.93

102.93

102.93

92.93

81.93